Chronic Viral Hepatitis in Human Immunodeficiency Virus-infected Patients
Author(s) -
Uluhan Sili,
Aysun Tekin,
Volkan Korten
Publication year - 2016
Publication title -
viral hepatitis journal
Language(s) - English
Resource type - Journals
eISSN - 2147-2939
pISSN - 1307-9441
DOI - 10.4274/vhd.07279
Subject(s) - human immunodeficiency virus (hiv) , virology , medicine , hepatitis a virus , chronic hepatitis , viral hepatitis , hepatitis virus , virus , immunology
Insan bagisiklik yetmezlik virusu ile enfekte hastalarda kronik hepatit B virusu (HBV) ve hepatit C virusu (HCV) enfeksiyonlari da arastirilmalidir. Bu hastalarda kronik viral hepatitler daha hizli ilerler ve siroz daha cabuk gelisir. Tani konulduktan sonra kronik viral hepatitler icin etkin tedavi verilebilir. HBV’nin replikasyonunu tenofovir iceren anti-retroviral tedaviler ile baskilamak mumkundur. Dogrudan etkili antiviral ilaclarin gelistirilmesiyle HCV enfeksiyonunun sagaltimi mumkun hale gelmistir. Anahtar Kelimeler: Insan bagisiklik yetmezlik virusu, kronik hepatit B, kronik hepatit C, ko-enfeksiyon Infectious diseases physicians taking care of human immunodeficiency virus-infected patients should investigate for the presence of chronic hepatitis caused by hepatitis B and hepatitis C virus infections. This is important as chronic viral hepatitis progresses more rapidly to end-stage liver disease in human immunodeficiency virus-infected patients. Once diagnosed, there are effective drugs for the treatment chronic viral hepatitis. Tenofovir containing anti-retroviral therapy effectively suppresses hepatitis B replication. Hepatitis C cure can be achieved with directly acting antiviral agents.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom